Long term azithromycin therapy in patients with cystic fibrosis
Inflammation is a central contributor to the pathogenesis of cystic fibrosis (CF) pulmonary disease; so limiting the excessive production of inflammatory mediators represents a major therapeutic strategy for slowing the decline in lung function and improving survival. The macrolide antibiotic...
Saved in:
| Main Authors: | Nagehan Emiralioğlu, Zeynelabidin Öztürk, Ebru Yalçın, Deniz Doğru, Uğur Özçelik, Nural Kiper |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2016-02-01
|
| Series: | The Turkish Journal of Pediatrics |
| Subjects: | |
| Online Access: | https://turkjpediatr.org/article/view/1067 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnosis of cystic fibrosis with chloride meter (Sherwood M926S chloride analyzer®) and sweat test analysis system (CFΔ collection system®) compared to the Gibson Cooke method
by: Nagehan Emiralioğlu, et al.
Published: (2016-02-01) -
Nasal nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and healthy children
by: Elif Güney, et al.
Published: (2019-02-01) -
The predictive role of lung clearance index on FEV1 decline in cystic fibrosis
by: Beste Özsezen, et al.
Published: (2024-07-01) -
Clinical findings of methicillin-resistant Staphylococcus aureus in cystic fibrosis
by: Beste Özsezen, et al.
Published: (2022-10-01) -
Diverse clinical characteristics of Aspergillus growth in patients with cystic fibrosis
by: Nagehan Emiralioğlu, et al.
Published: (2020-08-01)